MRNS
Marinus Pharmaceuticals Inc
Price:  
0.55 
USD
Volume:  
1,101,147.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRNS Fair Value

-2,412.91 %
Upside

What is the fair value of MRNS?

As of 2025-07-02, the Fair Value of Marinus Pharmaceuticals Inc (MRNS) is -12.72 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.55 USD, the upside of Marinus Pharmaceuticals Inc is -2,412.91%.

Is MRNS a good investment?

With the market price of 0.55 USD and our fair value calculation, Marinus Pharmaceuticals Inc (MRNS) is not a good investment. Investing in MRNS stocks now will result in a potential loss of 2,412.91%.

Note: valuation result may not be accurate due to the company's negative EPS.

0.55 USD
Stock Price
-12.72 USD
Fair Price
FAIR VALUE CALCULATION

MRNS Fair Value

Peter Lynch's formula is:

MRNS Fair Value
= Earnings Growth Rate x TTM EPS
MRNS Fair Value
= 5.00 x -2.54
MRNS Fair Value
= -12.72

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -54.12 -67.48 -98.78 -19.82 -141.40 -76.32
YoY growth -47.35% -24.69% -46.38% 79.94% -613.45% -130.39%

MRNS Fair Value - Key Data

Market Cap (mil) 30.37
P/E
Forward P/E
EPS -2.54
Avg earnings growth rate -130.39%
TTM earnings -140.49